To determine the impact of Ezh2 deletion on the development and progression of endometrial cancer induced by PTEN inactivation, we generated mice containing double deletion of Ezh2 and Pten using Cre recombinase driven by the progesterone receptor (Pgr) promoter. Here, PGR is linked to endometrial cancer.